EP4028704B1 - Séchage supercritique des milieux chromatographiques - Google Patents
Séchage supercritique des milieux chromatographiques Download PDFInfo
- Publication number
- EP4028704B1 EP4028704B1 EP20807103.5A EP20807103A EP4028704B1 EP 4028704 B1 EP4028704 B1 EP 4028704B1 EP 20807103 A EP20807103 A EP 20807103A EP 4028704 B1 EP4028704 B1 EP 4028704B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- protein
- drying
- composite material
- critical point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000352 supercritical drying Methods 0.000 title claims description 120
- 239000012501 chromatography medium Substances 0.000 title description 6
- 239000012528 membrane Substances 0.000 claims description 268
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 129
- 238000000034 method Methods 0.000 claims description 103
- 108090000623 proteins and genes Proteins 0.000 claims description 86
- 102000004169 proteins and genes Human genes 0.000 claims description 85
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 67
- 239000012530 fluid Substances 0.000 claims description 58
- 239000002131 composite material Substances 0.000 claims description 57
- 239000000499 gel Substances 0.000 claims description 53
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- 239000003446 ligand Substances 0.000 claims description 47
- 239000011148 porous material Substances 0.000 claims description 42
- 239000000463 material Substances 0.000 claims description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- 239000003495 polar organic solvent Substances 0.000 claims description 18
- 239000001569 carbon dioxide Substances 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 15
- 150000002500 ions Chemical class 0.000 claims description 13
- 239000000178 monomer Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- -1 ethylene, propylene, methanol Chemical class 0.000 claims description 12
- 239000004971 Cross linker Substances 0.000 claims description 10
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 10
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 10
- 125000000524 functional group Chemical group 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000007792 gaseous phase Substances 0.000 claims description 9
- 239000007791 liquid phase Substances 0.000 claims description 9
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 8
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 8
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 8
- 230000008020 evaporation Effects 0.000 claims description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 7
- 238000010926 purge Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 101710120037 Toxin CcdB Proteins 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000000017 hydrogel Substances 0.000 claims description 4
- 102000028557 immunoglobulin binding proteins Human genes 0.000 claims description 4
- 108091009323 immunoglobulin binding proteins Proteins 0.000 claims description 4
- 108010026228 mRNA guanylyltransferase Proteins 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000001272 nitrous oxide Substances 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000001294 propane Substances 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 108010074605 gamma-Globulins Proteins 0.000 claims description 3
- 102000018358 immunoglobulin Human genes 0.000 claims description 3
- 229940072221 immunoglobulins Drugs 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000018832 Cytochromes Human genes 0.000 claims description 2
- 108010052832 Cytochromes Proteins 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 102000000588 Interleukin-2 Human genes 0.000 claims description 2
- 108010002350 Interleukin-2 Proteins 0.000 claims description 2
- 102000015696 Interleukins Human genes 0.000 claims description 2
- 108010063738 Interleukins Proteins 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 102000016943 Muramidase Human genes 0.000 claims description 2
- 108010014251 Muramidase Proteins 0.000 claims description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 239000004325 lysozyme Substances 0.000 claims description 2
- 229960000274 lysozyme Drugs 0.000 claims description 2
- 235000010335 lysozyme Nutrition 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 239000000123 paper Substances 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 229920000867 polyelectrolyte Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920006393 polyether sulfone Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920006380 polyphenylene oxide Polymers 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 210000004379 membrane Anatomy 0.000 description 268
- 238000001035 drying Methods 0.000 description 70
- 239000000243 solution Substances 0.000 description 60
- 238000003860 storage Methods 0.000 description 47
- 230000008569 process Effects 0.000 description 45
- 239000000872 buffer Substances 0.000 description 36
- 239000004593 Epoxy Substances 0.000 description 34
- 239000002904 solvent Substances 0.000 description 27
- 238000012360 testing method Methods 0.000 description 27
- 230000004907 flux Effects 0.000 description 26
- 230000035699 permeability Effects 0.000 description 25
- 230000000694 effects Effects 0.000 description 23
- 239000007788 liquid Substances 0.000 description 19
- 239000006184 cosolvent Substances 0.000 description 17
- 125000003158 alcohol group Chemical group 0.000 description 14
- 229940027941 immunoglobulin g Drugs 0.000 description 13
- 238000002791 soaking Methods 0.000 description 12
- 230000003993 interaction Effects 0.000 description 11
- 238000000926 separation method Methods 0.000 description 10
- 239000012071 phase Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000002599 biostatic effect Effects 0.000 description 8
- 238000000643 oven drying Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 230000021615 conjugation Effects 0.000 description 5
- 239000013256 coordination polymer Substances 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000001614 effect on membrane Effects 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 125000003700 epoxy group Chemical group 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Chemical group 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000008863 intramolecular interaction Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000012621 metal-organic framework Substances 0.000 description 2
- 238000005935 nucleophilic addition reaction Methods 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000307 polymer substrate Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- AOUSBQVEVZBMNI-UHFFFAOYSA-N 2-bromoethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCBr AOUSBQVEVZBMNI-UHFFFAOYSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000270276 Natrix Species 0.000 description 1
- 239000004965 Silica aerogel Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- PBZROIMXDZTJDF-UHFFFAOYSA-N hepta-1,6-dien-4-one Chemical compound C=CCC(=O)CC=C PBZROIMXDZTJDF-UHFFFAOYSA-N 0.000 description 1
- 239000012145 high-salt buffer Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- FJYACARVIOXIAK-UHFFFAOYSA-N n'-hydroxyprop-2-enimidamide Chemical compound C=CC(N)=NO FJYACARVIOXIAK-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- LJAGLQVRUZWQGK-UHFFFAOYSA-N oxecane-2,10-dione Chemical compound O=C1CCCCCCCC(=O)O1 LJAGLQVRUZWQGK-UHFFFAOYSA-N 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- CMXPERZAMAQXSF-UHFFFAOYSA-M sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione Chemical compound [Na+].O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC CMXPERZAMAQXSF-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- FUSUHKVFWTUUBE-UHFFFAOYSA-N vinyl methyl ketone Natural products CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B21/00—Arrangements or duct systems, e.g. in combination with pallet boxes, for supplying and controlling air or gases for drying solid materials or objects
- F26B21/14—Arrangements or duct systems, e.g. in combination with pallet boxes, for supplying and controlling air or gases for drying solid materials or objects using gases or vapours other than air or steam, e.g. inert gases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
- B01J20/267—Cross-linked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28057—Surface area, e.g. B.E.T specific surface area
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28078—Pore diameter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28078—Pore diameter
- B01J20/2808—Pore diameter being less than 2 nm, i.e. micropores or nanopores
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28078—Pore diameter
- B01J20/28083—Pore diameter being in the range 2-50 nm, i.e. mesopores
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/291—Gel sorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/305—Addition of material, later completely removed, e.g. as result of heat treatment, leaching or washing, e.g. for forming pores
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B21/00—Arrangements or duct systems, e.g. in combination with pallet boxes, for supplying and controlling air or gases for drying solid materials or objects
- F26B21/06—Controlling, e.g. regulating, parameters of gas supply
- F26B21/10—Temperature; Pressure
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B3/00—Drying solid materials or objects by processes involving the application of heat
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B3/00—Drying solid materials or objects by processes involving the application of heat
- F26B3/02—Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/48—Sorbents characterised by the starting material used for their preparation
- B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
- B01J2220/4856—Proteins, DNA
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02C—CAPTURE, STORAGE, SEQUESTRATION OR DISPOSAL OF GREENHOUSE GASES [GHG]
- Y02C20/00—Capture or disposal of greenhouse gases
- Y02C20/40—Capture or disposal of greenhouse gases of CO2
Definitions
- SCF Supercritical fluid
- CPD critical point drying
- porous materials by developing reactive processes in supercritical CO 2 fluid for synthesizing empty-pore three-dimensional metal-organic frameworks (MOFs), as well as processing disordered porous materials, such as polymers, aerogels, and concrete.
- MOFs metal-organic frameworks
- Supercritical fluid technology is also used successfully for protein micronization, encapsulation in particles, making biopolymeric microporous foam (using supercritical foaming), and supercritical impregnation for developing biomedical and pharmaceutical formulations or devices.
- SCF can be used in variety of ways to produce the biopolymer. The choice of the method is highly dependent on: interaction of the supercritical fluid (e.g., CO 2 ) with the active ingredient (e.g., protein), the solvent, and the coating material of interest or the polymer, where the interaction of the polymer with the supercritical fluid (e.g., CO 2 ) plays an important role.
- the CPD technique was used to maintain or nearly maintain the wet pore structure, surface area, and the permeability of the membrane in the dried state. After exposing the composite material to a supercritical fluid, the composite material dries as the supercritical fluid evaporates with reduced pressure.
- the disclosure relates to methods of critical point drying a composite material, comprising the steps of:
- the disclosure relates to methods of critical point drying a composite material, comprising the steps of:
- the composite material is for bio-affinity chromatography.
- the composite material is a membrane.
- the composite material is a porous polymeric gel membrane.
- the CPD technique was used to maintain or nearly maintain the wet pore structure, surface area, and the permeability of the membrane in the dried state.
- the critical point drying method produces dried membranes that show consistent properties with storage, post-CPD, in the dried state.
- CPD is used as a drying approach to dry a bio-affinity media that has bioligand attached to porous gel or porous gel composite materials that can be used, among other applications, as chromatographic media for bio-separation.
- the CPD technique is used to dry the conjugated protein-polymer material while maintaining the structure and the functionality of the bio-affinity media.
- other drying methods can only preserve membrane properties for a limited storage time in the dried state.
- an element means one element or more than one element.
- polymer is used to mean a large molecule formed by the union of repeating units (monomers).
- polymer also encompasses copolymers.
- co-polymer is used to mean a polymer of at least two or more different monomers.
- a co-polymer can be comprised of a cross-linker and a monomer, if the cross-linker is a difunctional monomer.
- supercritical fluid SCF
- SCF supercritical fluid
- An important feature of supercritical fluids is that in the critical region the fluids show density like liquids, while the viscosity and diffusivity are similar to gases. Therefore, supercritical fluids have good mixing and mass transfer properties, and their capacity to solubilize any solute is not-surprisingly sensitive to both temperature and pressure. This variation of solubility at different temperature and pressure provide the opportunity to use supercritical fluids in several applications where solubilizing and precipitation/separation of solute can be controlled by changing the critical region conditions.
- Protein A or "PrA” is used to mean a bacterial protein from Staphylococcus aureus , a Protein A derivative, or a recombinant Protein A with the capacity to bind mammalian antibodies of class immunoglobulin G (IgG) with high affinity.
- the gene for Protein A has been cloned and expressed in Escherichia coli allowing for the production of large quantities of recombinant Protein A and Protein A derivatives.
- Protein A is an affinity ligand.
- Protein A is a protein, peptide, or recombinant protein comprising a ligand that binds monoclonal antibodies (e.g., IgG antibodies) and a moiety that can form a covalent bond with a pendant reactive functional group (e.g., thiol of Cys, or amine of Lys).
- a pendant reactive functional group e.g., thiol of Cys, or amine of Lys.
- Protein A is a protein, peptide, or recombinant protein comprising a ligand that binds with the Fc domain of an antibody and a moiety that can form a covalent bond with a pendant reactive functional group.
- Protein A is a protein, peptide, or recombinant protein comprising a ligand that binds with the Fab domain of an antibody and a moiety that can form a covalent bond with a pendant reactive functional group.
- Composite materials comprising pendant reactive functional groups can be grafted with ligands through chemical reactions.
- porous membranes containing active epoxy pendant groups can be grafted with bio-affinity ligands through nucleophilic conjugation reactions with suitable groups present on bio-affinity ligands.
- the conjugated membranes can serve as chromatographic media useful for bio-affinity separations of specific targets, such as monoclonal antibodies.
- the membrane platform should maintain a porous structure that produces sufficient permeability to flow and desired target binding capacity, and these features should be stable with storage.
- bio-affinity chromatographic media depends on the immobilized ligand specificity that allows it to bind selectively a specific target among other analytes, which can be released in subsequent steps, using mobile phases that reduce the binding forces between the ligand and the target.
- This bioactivity of the ligand depends largely on the geometrical structure as well as chemical structure of the active center, and therefore any changes in either the chemical structure or stereo structure are likely to impact the binding capacity of the chromatographic media.
- drying protein molecules exposes the biomolecule to various physical forces due to water removal and intra-molecular interaction forces that put pressure on the three-dimensional structure of the large molecule, which likely to result in changes in the 3D structure that are irreversible.
- freeze-drying also known as lyophilization
- SCF drying the emerging SCF drying technique.
- freeze-drying also known as lyophilization
- Supercritical fluid drying is relatively a new technique that also comes with different stresses on the protein structure as the high pressure associated with SCF process might influence the protein stability, and the use of organic solvents may result in denaturation or aggregation.
- an immobilized biomolecule may require a drying technique that can dry both the immobilized molecule and the platform as well, especially if the latter is a material sensitive to the drying technique.
- the membrane platform is usually made by in-situ polymerization of acrylate/acrylamide monomers and crosslinker on within non-woven fibrous polymer substrate to obtain porous enforced-gel material.
- epoxy-containing membrane was made using acrylate and acrylamide monomers and crosslinkers on non-woven fibrous polymer substrate to obtain a porous gel material.
- the porosity and the structure of the porous gel of the membrane was tuned by a thermal treatment process to produce desired properties, such as permeability and protein binding capacity.
- porous epoxy membrane has active epoxy groups and can be grafted with bio-affinity ligands through nucleophilic conjugation reaction that utilize amino groups on the bio-molecule.
- the epoxy membrane was conjugated with a bioligand through a two-step process of coupling the biomolecule through a nucleophilic addition reaction, followed by a capping step to reduce active epoxy groups on the surface.
- the conjugated membrane can serve as a chromatographic platform to perform bio-affinity separation of specific targets, such as monoclonal antibodies. In order to have good separation performance, the conjugated membrane should have good porous structure with high surface area and good permeability, as well as maintaining immobilized ligand bioactivity.
- Drying the conjugated membrane can increase the stability of the ligand, increase the shelf life of the biopolymer, facilitate the handling of the material, and reduce the risk of contamination.
- Two components must be considered while drying the bioaffinity media: the stability of the immobilized ligand and the stability of the polymer carrier.
- the properties of such obtained structure in the dry state was found to change over time.
- the sensitivity of the membrane gel to the drying process may be related to the pore structure of gel, which may be irreversibly altered during drying processes.
- drying the membrane gel from an aqueous wetting phase which has a relatively high surface tension, may expose the gel structure to high shear forces during the removal of the water in the drying step.
- the drying of the conjugated bioaffinity membrane is found to be challenging as the functionality and chromatographic performance of the membrane changes with drying process and continues to deteriorate with time. This has been observed for epoxy group containing membranes which have shown limited stability when dried either at room temperature or at higher temperatures (40-50 °C). In addition to the membrane platform sensitivity, ligand susceptibility to drying process stresses cannot be ignored and can be responsible for the loss of bioactivity.
- the ligand may be impacted by water removal, which expose the protein to various intra- and inter-molecular interaction forces, in the vicinity of the membrane surface.
- Biomolecule-surface interaction forces can alter the spatial structure of the protein, leading to denaturation and loss of activity.
- Critical point drying provides the opportunity to dry the membrane from a supercritical fluid (e.g., carbon dioxide) phase under very low surface tension condition that minimizes these forces on the membrane gel structure and thereby maintains the wet properties. That is, SCF provides an essentially zero surface tension environment to dry material due to the unique fluid properties at critical conditions, where gaseous and liquid phases can be indistinguishable.
- a supercritical fluid e.g., carbon dioxide
- Carbon dioxide is a good supercitical fluid candidate for critical point drying as it can reach a supercritical state under relatively mild conditions, compared to other liquid or gases.
- the critical point of water is at 374 °C and 228 bar, and these conditions may result in irreversible changes to many materials of interest. That is, the critical point of water presents a more difficult and extreme set of conditions to reach that may affect the polymer and the ligand, not only physically but possibly chemically.
- the critical point of carbon dioxide is at 31.2 °C and 73.8 bar, which are much less likely to irreversibly alter sample properties and require less stringent equipment design and controls.
- the CO 2 is non-toxic and cost-efficient for large scale processes.
- the water in the composite material to be dried e.g., the membrane
- a polar organic solvent such as an alcohol or a ketone
- the exchange fluid therefore must have good miscibility with water to permit the exchange process, and be miscible with CO 2 to allow a final exchange of the membrane into the CO 2 drying fluid.
- one hurdle to overcome is the expected negative effect of exposing biomolecules to these organic solvents.
- the temperature of the chamber where the material of interest (membrane) and the CO 2 drying fluid are enclosed is increased beyond the critical point temperature and pressure to the supercritical region, after which controlled evaporation by reducing pressure takes place, and drying occurs in the absence of surface tension forces.
- the exchange protocol must include an initial step of buffer/salt exchange to provide enough ions (to reduce intra-molecule ionic interactions during CSF drying), and to strictly use gradients of organic solvent that have low water content ( ⁇ 10%).
- the disclosure relates to methods of critical point drying a composite material, comprising the steps of:
- the disclosure relates to methods of critical point drying a composite material, comprising the steps of:
- the supercritical fluid is selected from the group consisting of carbon dioxide, water, methane, ethane, propane, ethylene, propylene, methanol, ethanol, acetone, and nitrous oxide. In some embodiments, the supercritical fluid is not water. In some embodiments, the supercritical fluid is selected from the group consisting of carbon dioxide, methane, ethane, propane, ethylene, propylene, methanol, ethanol, acetone, and nitrous oxide. In some embodiments, the supercritical fluid is carbon dioxide.
- one or more of the following parameters selected from the group consisting of total amount of supercritical fluid relative to sample volume, number of purge cycles, temperature during contact with the supercritical fluid, the exchange rate with the supercritical fluid, the temperature during the evaporation step, the heating rate to increase temperature, and the rate of the pressure reduction can be varied in the methods disclosed herein.
- parameters that can be varied to affect the drying process include: 1) the total amount of liquid CO 2 (or number of purge cycles) relative to sample volume, 2) the chamber temperature during CO 2 exchange, the liquid CO 2 exchange rate, 3) the temperature set for the drying step (typically higher than Tc), 4) the heating rate at which the chamber temperature increases, and 5) the CO 2 pressure decline rate during the evaporation step.
- the polar organic solvent is selected from the group consisting of acetone, acetonitrile, ammonia, t-butanol, n-propanol, ethanol, methanol, and acetic acid.
- the support member comprises a polymeric material selected from the group consisting of polysulfones, polyethersulfones, polyphenyleneoxides, polycarbonates, polyesters, cellulose, and cellulose derivatives.
- the composite material is a membrane.
- the composite material is in contact with one or more interleaf layers.
- the one or more interleaf layers are selected from the group consisting of screen, polypropylene, polyethylene, and paper.
- the cross-linked gel is a neutral hydrogel, a charged hydrogel, a polyelectrolyte gel, a hydrophobic gel, a neutral gel, or a gel comprising functional groups.
- the composite materials used as membranes in the present invention are described in US Patent Nos. 7,316,919 ; 8,206,958 ; 8,187,880 ; 8,211,682 ; 8,652,849 ; 8,192,971 ; 8,206,982 ; 8,367,809 ; 8,383,782 ; 8,133,840 ; 9,962,691 ; and 10,357,766 ; and US Patent Application Serial Nos. 14/190,650 , 16/055,786 , and 16/516,5 00 .
- the macroporous cross-linked gel comprises macropores having an average size of about 10 nm to about 3000 nm.
- the pores of the support member have an average pore diameter of about 0.1 ⁇ m to about 50 ⁇ m.
- the cross-linked gel comprises pendant reactive functional groups.
- the pendant reactive functional groups are selected from the group consisting of aldehydes, amines, carbon-carbon double bonds, carbon-carbon triple bonds, epoxides, hydroxyls, thiols, anhydrides, azides, reactive halogens, acid chlorides, and a mixture thereof.
- the pendant reactive functional groups are epoxides.
- the one or more monomers comprising a pendant reactive functional group are selected from the group consisting of glycidyl methacrylate, acrylamidoxime, acrylic anhydride, azelaic anhydride, maleic anhydride, hydrazide, acryloyl chloride, 2-bromoethyl methacrylate, and vinyl methyl ketone.
- the cross-linked gel comprises a plurality of ligands. In some embodiments, the cross-linked gel comprises a plurality of ligands comprising a functionality. In some embodiments, the functionality is selected from the group consisting of cationic, anionic, hydrophobic, hydrophilic, thiophilic, hydrogen bond donating, hydrogen bond accepting, pi-pi bond donating, pi-pi bond accepting, metal chelating, a biological molecule, and a biological ion.
- the plurality of ligands are biological molecules or biological ions selected from the group consisting of albumins, lysozyme, viruses, cells, ⁇ -globulins of human and animal origins, immunoglobulins of both human and animal origins, proteins of recombinant or natural origin including, polypeptides of synthetic or natural origin, interleukin-2 and its receptor, enzymes, monoclonal antibodies, antigens, lectins, bacterial immunoglobulin-binding proteins, trypsin and its inhibitor, cytochrome C, myoglobulin, recombinant human interleukin, recombinant fusion protein, Protein A, Protein G, Protein L, Peptide H, nucleic acid derived products, DNA of either synthetic or natural origin, and RNA of either synthetic or natural origin.
- the plurality of ligands are biological molecules or biological ions selected from the group consisting of ⁇ -globulins of human and animal origins, immunoglobulins of both human and animal origins, proteins of recombinant or natural origin including, polypeptides of synthetic or natural origin, monoclonal antibodies, bacterial immunoglobulin-binding proteins, recombinant fusion protein, Protein A, Protein G, and Protein L.
- the plurality of ligands are biological molecules or biological ions selected from the group consisting of a polypeptide, a protein, a recombinant protein, a bacterial immunoglobulin-binding protein, a recombinant fusion protein, Protein A, Protein G, Protein L, and Peptide H. In some embodiments, the plurality of ligands are Protein A.
- the composite materials comprise polymers that contain various ligands useful for affinity chromatography.
- chromatographic separation of biomolecules e.g., proteins
- this approach can be used to introduce to the composite materials (e.g., membrane) ion exchange functionalities (e.g., carboxylate, sulfonate, quaternary ammonium, amine), hydrophobic interaction moieties (such as octyl group by using 1-octanethiol or 1-octene), and biomolecules for bio-affinity chromatography (such as cysteine-protein A for monoclonal antibody purification).
- ion exchange functionalities e.g., carboxylate, sulfonate, quaternary ammonium, amine
- hydrophobic interaction moieties such as octyl group by using 1-octanethiol or 1-octene
- biomolecules for bio-affinity chromatography such as cysteine-protein A for monoclonal antibody
- the composite materials demonstrate instability in and after conventional drying processes.
- critical point drying allows removal of water without damaging the composite material.
- critical point drying allows removal of water without damaging the membrane comprising ligands.
- the invention relates to methods of critical point drying of composite materials such that the composite materials show equivalent properties to initial water wet composite materials.
- the methods of critical point drying of composite materials improve composite material storage, assembly of a membrane into the final device, and stable shipping with reduced bioburden load.
- Liquified carbon dioxide (medical grade 99.99%) was obtained from PraxAir Canada Inc., anhydrous alcohol reagent ( ⁇ 0.005% water) and calcium chloride were obtained from MilliporeSigma, and buffer solution 10X PBS liquid concentrate (Grow Cells) was purchased from VWR.
- Epoxy membranes were made by polymerizing acrylate and or acrylamide monomers and crosslinkers within a support mesh material in a UV initiated reaction.
- Various functional membranes containing protein binding groups e.g. ion exchange, hydrophobic interaction and hydrophilic interaction
- the wet washed membranes may also be subjected to an additional thermal treatment step to tune their performance, final pore structure, and permeability.
- the epoxy membrane was conjugated with Protein A ligand through nucleophilic addition reaction where mostly a nucleophilic group on the ligand molecule (amino or thiol groups) open the oxirane ring and covalently bind the bioligand to the membrane gel.
- ligands can also be conjugated to target other bio-molecules or entities such as viruses.
- a membrane disc 25 mm was mounted in a Natrix stainless steel holder then connected to an AKTA chromatography instrument, where the membrane was equilibrated with PBS, then the ligand (Protein A) solution in phosphate buffer solution was passed through the membrane under selected flowrate(s) for an appropriate length of time. This was followed by buffer wash step then the unreacted epoxy groups of the membrane were passivated by flowing a quenching solution through the membrane, followed by a buffer wash step remove residual quenching solution.
- Membranes were evaluated for their permeability (at both pre and post-conjugated states when ligands were conjugated to membranes containing pendant reactive groups) and for their binding capacity for specific biomolecule target.
- Membrane binding capacity was measured by determining the amount of selected protein captured by a test volume membrane under defined flow conditions (i.e. dynamic binding capacity, dBC) and expressed as mg protein bound/mL of membrane.
- dBC dynamic binding capacity
- binding capacity was measured by determining the amount of IgG protein captured by the active membrane volume at 10% breakthrough absorbance the passing testing solution of the target molecule in buffer (IgG in this case).
- the dynamic binding capacity (dBC) expressed as mg of target molecule /mL of membrane volume.
- Membrane samples were generally solvent exchanged and critical point dried in a roll format. Membrane strips were layered with strips of polypropylene screen of similar width and slightly longer length (2-3 cm longer) then rolled up ( Fig. 1A ). The rolls were made in dimensions that fit into the critical point drying (CPD) chamber sample holder (mostly 4 cm in width and OD of ⁇ 4.5 cm) or in some cases fits directly in the instrument chamber itself (width ⁇ 5.5cm and OD below 5.8cm).
- CPD critical point drying
- Membrane samples were exchanged and dried in hand-made roll format. Protein A Membrane strips ( ⁇ 4x36 cm) were layered with PP screens of similar width and slightly longer strips (2-3 cm longer) then rolled up ( Fig. 1A ). The screens were used to improve the exchange process and process consistency. The rolls were made in dimensions that fit the instrument holder (mostly 4 cm in width and OD of ⁇ 4.5 cm) or in some cases fits directly in the instrument chamber itself (width ⁇ 5.5cm and OD below 5.8 cm). A wire was used to keep the interleafed roll together during the exchange process, which was carried out in 200 mL beaker, then was removed just before placing the roll into the holder (or the chamber for the larger roll setup).
- Membrane samples were critical point dried as an interchanging stack of membrane and screen discs of the same diameter. After being fully exchanged in a separate container with the appropriate solution volume in each step according to the protocol, the membrane discs (25 mm) were stacked in a modified sample block (with an ID of 25 mm) with screen discs of same diameter interchangeably, as shown in Fig. 1B .
- the screens discs serve as separators to promote better mixing and accessibility during the solvent exchange step, as well as the CPD drying process in which exchanging alcohol with CO 2 is crucial for successful drying.
- the stack was soaked briefly in fresh amount of anhydrous alcohol before being mounted onto the exchange chamber of the CPD instrument.
- Carbon dioxide critical pressure and temperature are 73.8 bar and 31.2°C, respectively. These mild conditions to reach for supercritical fluid status makes carbon dioxide a suitable choice for performing critical point drying while preserving fragile structures during the process.
- the poor miscibility of water in CO 2 makes it necessary to exchange the water with ethanol, a more CO 2 miscible intermediate liquid phase that can be easily replaced with liquid carbon dioxide prior to the drying process.
- a membrane roll was usually transferred into the ethanol exchange fluid via a water ethanol gradient to ultimately replace the aqueous phase in the membrane with anhydrous alcohol that possess very low water content.
- Several protocols were examined that have different number of steps, variable alcohol content, and residence time(s). Mainly, two protocols were examined: Protocol A with five short steps with gradual decrease in water content (Table 1) and protocol B with eight steps (Table 2). Table 1.
- Solvent Exchange Protocol B Step Alcohol Solution % Soaking Time (min) 1 30 10 2 70 10 3 70 10 4 90 10 5 90 10 6 100 10 7 100 10 8 100 10
- the exchange protocol for CPD involves exchanging the subject in ascending gradient solution of alcohol in water, ending with anhydrous alcohol soak/exchange to remove all water before going to the SCF step and eventually evaporating the CO 2 by reducing the pressure to make the transition from supercritical phase into gaseous phase.
- the exchange protocol was modified to minimize or mitigate the expected negative effects of exposure of the ligand molecule to organic solution(s).
- the initial step of the exchange protocol is designed to promote enriching the membrane and the ligand with counter ions by performing an extended soak in a buffer solution.
- the membrane was transitioned from a 100% aqueous phase directly into 90% alcohol-content phase to avoid exposing the protein to alcohol mixtures of high-water content that may promote denaturation.
- the exchange hold times were limited to avoid prolonged exposure to alcohol solution(s).
- the critical point drying (CPD) process was carried out using a Leica EM CPD300 equipped with a liquid carbon dioxide tank that has siphon tube for liquid CO 2 discharge ( ⁇ 55 bar) and a separator bottle to collect extracted ethanol from the outlet CO 2 /alcohol mixture.
- the membrane roll was placed in the cylindrical holder within the chamber, and anhydrous ethanol solution was added until the sample is mostly covered with ethanol, then the lid was tightened to seal the chamber.
- the chamber could be cooled first to the set temperature, then the membrane roll was loaded up as previously described.
- the instrument program started the process automatically by cooling down the chamber to the designated filling temperature (10 or 15 0 C), then feeding in the liquid CO 2 to fill the chamber.
- the alcohol purging process starts by injecting liquid CO 2 over multiple cycles (12-99 cycles) where fresh CO 2 replaces a portion of the solution mixture in the chamber in each cycle and in a continuous manner, while maintaining the pressure in the chamber within a certain range (maintaining CO 2 in the liquid state).
- the instrument switched to a heating step where the chamber temperature was increased beyond the critical temperature (34-36 0 C) and the pressure was set above the critical pressure (> 74 bar) so the membrane was now immersed in supercritical CO 2 liquid.
- the evaporation process took place by releasing the CO 2 slowly and reducing the pressure while maintaining the temperature, which allowed the transition from supercritical phase to the gaseous phase in the absence of any significant surface tension forces.
- the process ended by bringing the final pressure to 1 bar at which the dry membrane would be removed from the chamber.
- the instrument allows some control over the heating/evaporation step as the speed can be set at three different levels.
- Membrane pore size (diameter) was measured using 3G Porometer, a capillary flow porometer (Quantochrome Instruments, Boynton Beach, FL), operated by 3GWin software (V2.2).
- the membrane disc was placed on stainless steel mesh support disc within the designated holder, with the membrane facing up. The metal cover was then gently placed on the holder and closed, then the test was carried out within the pressure range of between 0-200 psi.
- the ethanol-wet membrane roll was placed in the critical point drying instrument chamber (Leica CPD300) and subjected to a purging process to replace ethanol with liquid CO 2 , followed by transferring the drying chamber conditions to the supercritical state (34 °C and 79 bar), and finally releasing the pressure to evaporate the supercritical fluid CO 2 .
- the critical point drying instrument chamber Leica CPD300
- the supercritical state 34 °C and 79 bar
- Protocol A the membrane is exchanged with ethanol solutions to replace water in membrane with alcohol through a five-step exchange protocol that uses solutions of gradually decreasing of water content to eventually reach exchanging steps with anhydrous ethanol reagent.
- protocol B the exchange process takes place over eight exchange steps thoroughly to replace water in the membrane with ethanol.
- the two protocols A and B are outlined in Table 1 and Table 2, respectively.
- Epoxy membrane samples were exchanged with ethanol, using protocol B (Table 2), then the membranes were dried using the following methods: A) Critical point drying; B) Membrane was soaked in water then dried in oven at 50 °C for 10 min; and finally C) Membrane was dried directly from ethanol in oven at 50 °C for 10 min.
- the membrane coupon was exchanged in 5-10 mL Porofil solution in a beaker for ⁇ 10-15 min to exchange ethanol with Porofil test fluid prior to testing.
- a small disc of each membrane (18 mm dia.) was soaked in Porofil solution for at least 10 min prior to testing (as outlined in method section).
- Example 7 Surface area of critical point dried epoxy membrane compared to oven drying
- any membrane plays an important role in determining its interaction extent with targeted molecules in mobile phase, as most adsorption processes, especially in bio-separation, take place at the interface.
- Larger accessible surface area in general means larger binding capacity where chances of biomolecules to interact with functional surfaces, whether through ionic, hydrophobic, or bio-affinity interactions increase proportionally with the increase in surface area.
- the surface areas ( Fig. 11 ) of several CPD membranes were substantially larger than the oven dried sample, with the CPD membrane surface areas ranging from 22-25 m 2 /g, compared to only 4.3 m 2 /g for the oven dried membrane.
- gel collapse with simple oven drying significantly reduces total membrane surface area and related binding capacity.
- Critical point drying (from liquid CO 2 ) has proven to be a suitable process for drying membranes in order to preserve their wet state properties and maintain membrane properties over long storage times. While the permeability and the binding capacity of the conjugated form of such membranes change drastically when dried from water or ethanol, even at relatively mild temperatures, their counterparts which were dried using critical point drying possessed permeabilities and binding capacities similar to their wet from. It was shown through various examples that critical point drying technique can reduce drying effect on membrane gel pore size and result in membranes with high surface area, compared to other methods.
- Example 8 Critical point drying of Protein A membrane in comparison to regular drying
- typical CPD method was used to dry a Protein A conjugated membrane and the resultant materials were compared to other drying methods for Protein A membrane (oven drying at 40 °C for 20 min).
- Protein A membrane was made by conjugating Protein A ligand to epoxy-containing membrane(s) (in disc format), following the conjugation method outlined in Example 1, Membrane Material section. Membrane coupons were tested before drying to determine their binding capacity and their flux to establish an undried baseline.
- the membrane discs were exchanged using protocol C, a typical gradient exchange system that uses alcohol solutions, as outlined in Table 3 ( Fig. 2 ).
- the membrane discs were loaded into the holder using screens discs of same diameter as separators, to promote better mixing and exchanging efficiency, then the holder with the membrane discs/screens stack was loaded into the CPD instrument and CPD process proceeded as described in the experimental section ( Fig. 12 ; Table 6).
- the bioaffinity membrane was dried using a modified exchange protocol that included a long soaking step with a buffer solution with the aim to providing counter ions to the protein in order to increase the stability of the protein when exposed to the organic phases (both the alcohol solution and liquid CO 2 ), and the high pressure during CPD process.
- Two protocols, namely Awb3 and Awb7 were developed, where the first step of both protocols is a relatively long soak of membrane in a high salt buffer solution (5X and 10X of PBS, respectively), as outlined in Table 3 ( Fig. 2 ).
- the developed protocols avoid exposing the ligand to organic solutions that have relatively large amount of water, as intermediate mixtures of water/organic solutions may increase the risk of ligand denaturation and resultant loss of bioactivity. Therefore, the buffer step in both protocols was followed by sharp increases in organic fluid content from 0% to 90% in the following two steps. In general, proteins may be more stable in organic solutions of low water content.
- the CPD proceeds as previously described ( Fig. 12 ; Table 6).
- the interleafed membrane roll was made as outlined in previous section, then it was exchanged from aqueous solution into an essentially pure ethanol solution using the developed protocol AwB3 (Table 7) that includes a buffer exchange step at the beginning of the exchange process.
- the membrane roll was simply placed in the designated amount of solution in a 200mL beaker then and was exchanged over the designated time with agitation every 2-3 minutes. At the end of every step, the solution was decanted, and fresh amount of the solution was added, following the composition outlined in the table.
- the membrane roll was transferred into the CPD instrument pre-cooled chamber and the process proceeded following the designated program in auto-mode, with pre-defined key parameters, as shown in (Table 8). Table 7.
- the membrane interleafed roll was exchanged using a modified (short version) protocol, as outlined in Table 9 (AwB3-SV), where the membrane was exchanged first with buffer (5X PBS) then went through limited alcohol exchange process that is comprised of 2 steps, instead of the usual 4 steps in the original AwB3 protocol.
- a protocol that included a first storage period in biostatic solution(s) before proceeding to the alcohol exchange and CP drying processes was split into two sub-protocols: 1) the step where the membrane is prepared and transferred into biostatic storage solution, and 2) alcohol exchange step where a simplified shorter protocol is applied to exchange the storage solution for essentially pure alcohol in preparation for the CP drying process.
- TP2-AWOB1 In alternative protocol (TP2-AWOB1, Table 11), the membrane roll is exchanged with buffer solution (5X PBS) first to allow sufficient ionic group incorporation, after which the membrane is exchanged in 20% alcohol (in water) then stored for a short period of time (1day for the first set, or 7days for the second set). At the end of each experiment storage period, the membrane is subjected to an exchange protocol to replace the primarily aqueous storage solutions with alcohol in preparation for the CP drying process. Table 10.
- buffer solution 5X PBS
- salt instead of buffer as a source of ions, particularly multivalent cations such as divalent calcium cation, to modify the solvent exchange system prior to CPD process was demonstrated.
- Divalent calcium cations are well known to impact protein structure through coordination bonds that serve to stabilize biomolecule structure in solution.
- calcium salt has good solubility in anhydrous alcohols solution, an advantage that PBS buffer does not have. This would allow a continued supply of calcium cations to the membrane during the last few steps of the exchange protocol to ensure the cations remain in contact with the membrane before moving to CPD process.
- Protein A membrane discs were made by functionalizing epoxy-containing membranes, then exchanged similarly but following AwB9 protocol (Table 3; Fig. 2 ) that has calcium chloride solution (2 M) in water instead of PBS buffer solutions, then critical point dried as outlined previously using key parameters listed in Table 6 ( Fig. 12 ; Program 8).
- Fig. 16A and 16B demonstrated the positive effect of incorporating calcium cation in the exchange protocol (AwB9) compared to Protocol C, particularly on binding capacity that remains essentially unchanged, and only a minor initial drop in membrane flux. Long term dry storage testing showed that the membrane flux and binding capacity were consistent over the selected test period ( Fig. 17 ).
- This invention provides the opportunity to use CPD approach to handle and dry a wide range of materials that contain a sensitive ligand and robust matrix or membrane, or robust bioligand on labile matrix or membrane, or sensitive bioligand immobilized on labile matrix or membrane.
- the CPD process and related exchange protocols must be modified to accommodate the sensitivity of either the bioligand or the platform on which the ligand is immobilized.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Peptides Or Proteins (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Extraction Or Liquid Replacement (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Drying Of Solid Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Claims (15)
- Procédé de séchage au point critique d'un matériau composite, comprenant les étapes de :a. production d'un matériau composite comprenant :i. un élément support, comprenant une pluralité de pores s'étendant à travers l'élément support ; etii. un gel réticulé macroporeux, ledit gel réticulé macroporeux comprenant un polymère formé à partir d'une réaction d'un ou plusieurs monomères polymérisables avec un ou plusieurs agents de réticulation ; ledit gel réticulé macroporeux se trouvant dans les pores de l'élément support ; et lesdits macropores du gel réticulé macroporeux étant plus petits que les pores de l'élément support ;ledit matériau composite étant mouillé avec une solution aqueuse ;b. échange de la solution aqueuse avec un solvant organique polaire, de sorte que le matériau composite soit mouillé avec le solvant polaire organique ;c. mise en contact du matériau composite avec un fluide supercritique à une température et une pression supérieures à celles du point critique du fluide supercritique, les phases gazeuse et liquide étant indifférenciables ; et ledit solvant organique polaire étant miscible au fluide supercritique ; etd. réduction de la pression ;ce qui permet le séchage au point critique du matériau composite.
- Procédé selon la revendication 1,
ledit gel réticulé macroporeux comprenant une pluralité de ligands qui sont des molécules biologiques ou des ions biologiques. - Procédé selon l'une quelconque des revendications 1 à 2, ledit fluide supercritique étant choisi dans le groupe constitué par le dioxyde de carbone, l'eau, le méthane, l'éthane, le propane, l'éthylène, le propylène, le méthanol, l'éthanol, l'acétone et l'oxyde nitreux.
- Procédé selon l'une quelconque des revendications 1 à 2, ledit fluide supercritique étant choisi dans le groupe constitué par le dioxyde de carbone, le méthane, l'éthane, le propane, l'éthylène, le propylène, le méthanol, l'éthanol, l'acétone et l'oxyde nitreux.
- Procédé selon l'une quelconque des revendications 1 à 2, ledit fluide supercritique étant le dioxyde de carbone.
- Procédé selon l'une quelconque des revendications 1 à 5, un ou plusieurs paramètres choisis dans le groupe constitué par la quantité totale de fluide supercritique par rapport au volume d'échantillon, le nombre de cycles de purge, la température pendant le contact avec le fluide supercritique, le taux d'échange avec le fluide supercritique, la température pendant l'étape d'évaporation, la vitesse de chauffage et la vitesse de la réduction de pression étant réglés.
- Procédé selon l'une quelconque des revendications 1 à 6, ledit solvant organique polaire étant choisi dans le groupe constitué par l'acétone, l'acétonitrile, l'ammonique, le t-butanol, le n-propanol, l'éthanol, le méthanol et l'acide acétique.
- Procédé selon l'une quelconque des revendications 2 à 7, lesdites molécules biologiques ou lesdits ions biologiques étant choisis dans le groupe constitué par les albumines, un lysozyme, les virus, les cellules, les γ-globulines d'origines humaine et animale, les immunoglobulines d'origine aussi bien humaine qu'animale, les protéines d'origine recombinante ou naturelle dont les polypeptides d'origine synthétique ou naturelle, l'interleukine-2 et son récepteur, les enzymes, les anticorps monoclonaux, les antigènes, les lectines, les protéines bactériennes de liaison aux immunoglobulines, la trypsine et son inhibiteur, le cytochrome C, la myoglobuline, une interleukine humaine recombinante, une protéine de fusion recombinante, la protéine A, la protéine G, la protéine L, le peptide H, les produits dérivés d'acides nucléiques, l'ADN d'origine soit synthétique soit naturelle, et l'ARN d'origine soit synthétique soit naturelle ;
éventuellement lesdites molécules biologiques ou lesdits ions biologiques étant la protéine A. - Procédé selon l'une quelconque des revendications 1 à 8, ledit élément support comprenant un matériau polymère choisi dans le groupe constitué par les polysulfones, les polyéthersulfones, les oxydes de polyphénylène, les polycarbonates, les polyesters, la cellulose et les dérivés de cellulose.
- Procédé selon l'une quelconque des revendications 1 à 9, ledit matériau composite étant une membrane.
- Procédé selon l'une quelconque des revendications 1 à 10, ledit matériau composite étant en contact avec une ou plusieurs couches intermédiaires.
- Procédé selon la revendication 11, lesdits une ou plusieurs couches intermédiaires étant choisies dans le groupe constitué par un écran, le polypropylène, le polyéthylène et le papier.
- Procédé selon l'une quelconque des revendications 1 à 12, ledit gel réticulé étant un hydrogel neutre, un hydrogel chargé, un gel polyélectrolytique, un gel hydrophobe, un gel neutre ou un gel comprenant des groupes fonctionnels.
- Procédé selon l'une quelconque des revendications 1 à 13, ledit gel réticulé macroporeux comprenant des macropores comportant une taille moyenne d'environ 10 nm à environ 3000 nm.
- Procédé selon l'une quelconque des revendications 1 à 14, lesdits pores de l'élément support comportant un diamètre moyen de pore d'environ 0,1 µm à environ 50 µm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP24165078.7A EP4365528A3 (fr) | 2019-09-13 | 2020-09-14 | Séchage supercritique des milieux chromatographiques |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962900155P | 2019-09-13 | 2019-09-13 | |
US201962900798P | 2019-09-16 | 2019-09-16 | |
PCT/IB2020/000832 WO2021048633A1 (fr) | 2019-09-13 | 2020-09-14 | Séchage supercritique de milieux chromatographiques |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP24165078.7A Division EP4365528A3 (fr) | 2019-09-13 | 2020-09-14 | Séchage supercritique des milieux chromatographiques |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4028704A1 EP4028704A1 (fr) | 2022-07-20 |
EP4028704B1 true EP4028704B1 (fr) | 2024-04-03 |
Family
ID=73401850
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20807103.5A Active EP4028704B1 (fr) | 2019-09-13 | 2020-09-14 | Séchage supercritique des milieux chromatographiques |
EP24165078.7A Pending EP4365528A3 (fr) | 2019-09-13 | 2020-09-14 | Séchage supercritique des milieux chromatographiques |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP24165078.7A Pending EP4365528A3 (fr) | 2019-09-13 | 2020-09-14 | Séchage supercritique des milieux chromatographiques |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220341664A1 (fr) |
EP (2) | EP4028704B1 (fr) |
JP (1) | JP2022550510A (fr) |
KR (1) | KR20220103093A (fr) |
CN (1) | CN114787571A (fr) |
AU (1) | AU2020345049A1 (fr) |
CA (1) | CA3153672A1 (fr) |
WO (1) | WO2021048633A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3232758A1 (fr) * | 2021-10-11 | 2023-04-20 | Amgen Inc. | Determination de la taille des pores d'un microfiltre |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565961B2 (en) * | 1997-03-07 | 2003-05-20 | Koslow Technologies Corporation | Absorbent articles |
AU7690198A (en) * | 1997-05-22 | 1998-12-11 | Trustees Of Princeton University, The | Lyotropic liquid crystalline l3 phase silicated nanoporous monolithiccomposites and their production |
JP2005008424A (ja) * | 2002-07-10 | 2005-01-13 | Matsushita Electric Ind Co Ltd | 多孔体およびその製造方法 |
JP5189286B2 (ja) | 2003-02-19 | 2013-04-24 | ナトリックス セパレイションズ インコーポレーテッド | 支持型多孔質ゲルを含んでなる複合材 |
AU2005231532B2 (en) * | 2004-04-08 | 2010-01-07 | Merck Millipore Ltd. | Membrane stacks |
JP4806401B2 (ja) | 2004-06-07 | 2011-11-02 | ナトリックス セパレイションズ インコーポレーテッド | 支持型多孔質ゲルを含む安定な複合材料 |
CN101851398A (zh) * | 2010-05-12 | 2010-10-06 | 北京理工大学 | 一种导电高分子气凝胶及其制备方法 |
US20120231251A1 (en) * | 2011-03-09 | 2012-09-13 | Samsung Electronics Co., Ltd. | Composition for clay-aerogel composite, clay-aerogel composite, and method of making the same |
WO2013003616A1 (fr) * | 2011-06-30 | 2013-01-03 | E. & J. Gallo Winery | Colorant cristallin naturel et son procédé de production |
KR20150131298A (ko) * | 2013-03-14 | 2015-11-24 | 나트릭스 세퍼레이션즈, 인코포레이티드 | 부식 조건 하에 안정한 크로마토그래피 막 |
US9962691B2 (en) * | 2015-02-20 | 2018-05-08 | Natrix Separations Inc. | Chromatography membranes formed by thiol-ene or thiol-yne click polymerization reactions |
KR102453735B1 (ko) * | 2016-03-25 | 2022-10-11 | 쇼와덴코머티리얼즈가부시끼가이샤 | 졸 조성물, 에어로겔 복합체, 에어로겔 복합체 구비 지지 부재 및 단열재 |
CN105853474A (zh) * | 2016-06-14 | 2016-08-17 | 南京华宽信息咨询中心 | 一种银杏内酯的提取方法及银杏内酯提取物 |
GB2571292B (en) * | 2018-02-22 | 2020-09-09 | Graphene Composites Ltd | Composite structure and method of manufacture |
-
2020
- 2020-09-14 CA CA3153672A patent/CA3153672A1/fr active Pending
- 2020-09-14 US US17/642,322 patent/US20220341664A1/en active Pending
- 2020-09-14 EP EP20807103.5A patent/EP4028704B1/fr active Active
- 2020-09-14 EP EP24165078.7A patent/EP4365528A3/fr active Pending
- 2020-09-14 KR KR1020227012096A patent/KR20220103093A/ko unknown
- 2020-09-14 AU AU2020345049A patent/AU2020345049A1/en active Pending
- 2020-09-14 WO PCT/IB2020/000832 patent/WO2021048633A1/fr unknown
- 2020-09-14 CN CN202080063918.4A patent/CN114787571A/zh active Pending
- 2020-09-14 JP JP2022515628A patent/JP2022550510A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220341664A1 (en) | 2022-10-27 |
CA3153672A1 (fr) | 2021-03-18 |
KR20220103093A (ko) | 2022-07-21 |
EP4365528A3 (fr) | 2024-07-17 |
CN114787571A (zh) | 2022-07-22 |
EP4365528A2 (fr) | 2024-05-08 |
JP2022550510A (ja) | 2022-12-02 |
WO2021048633A1 (fr) | 2021-03-18 |
EP4028704A1 (fr) | 2022-07-20 |
AU2020345049A1 (en) | 2022-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021250856B2 (en) | Chromatography membranes formed by thiol-ene or thiol-yne click polymerization reactions | |
JP5189286B2 (ja) | 支持型多孔質ゲルを含んでなる複合材 | |
Zou et al. | Affinity membrane chromatography for the analysis and purification of proteins | |
EP1773485B1 (fr) | Materiau composite stable comprenant des gels poreux supportes | |
Shi et al. | Functionalized anodic aluminum oxide (AAO) membranes for affinity protein separation | |
JP4699556B2 (ja) | タンパク吸着材料およびその製造方法 | |
JP7068316B2 (ja) | 巨大分子の精製のための高分子メッシュの利用 | |
JP5547281B2 (ja) | グラフトポリマーを有する多糖類マトリックス、その製造方法およびその使用 | |
BRPI0612720B1 (pt) | método de preparação de uma matriz de separação | |
EP4028704B1 (fr) | Séchage supercritique des milieux chromatographiques | |
Vlakh et al. | Molecular imprinting: A tool of modern chemistry for the preparation of highly selective monolithic sorbents | |
US20130244229A1 (en) | Buffering compositions enclosed in a size exclusion matrix | |
Song et al. | Synthesis of porous molecularly imprinted polymers for selective adsorption of glutathione | |
JPWO2018181738A1 (ja) | 分離材 | |
Bereli et al. | Antibody purification using porous metal–chelated monolithic columns | |
JP2023502481A (ja) | 複合材料に配位子をカップリングするための方法 | |
Adikane et al. | Chemical modification of ethyl cellulose-based highly porous membrane for the purification of immunoglobulin G | |
Jin et al. | Novel method for human serum albumin adsorption/separation from aqueous solutions and human plasma with Cibacron Blue F3GA-Zn (II) attached microporous affinity membranous capillaries | |
Ellingsen et al. | Monosized polymer particles in biochemical and biomedical separations | |
Mai et al. | Sizeable macroporous monolithic polyamide entities prepared in closed molds by thermally mediated dissolution and phase segregation | |
Koç et al. | Synthesis and Characterization of Macroporous Poly Acrylamide-Methacrylamido Histidine Cryogels and Their Use in Antibody Purification | |
Avramescu | Membrane adsorbers: development and applications | |
Barroso | Preparation of Affinity Membranes using Alternative Solvents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220331 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230602 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20231220 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602020028464 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |